Hong Kong News

Nonpartisan, Noncommercial, unconstrained.
Thursday, Feb 02, 2023

16,000 Hong Kong patients receive new oral anti-Covid drugs

16,000 Hong Kong patients receive new oral anti-Covid drugs

Hospital Authority has bought antiviral drugs molnupiravir, made by US firm MSD, and Pfizer’s Paxlovid, with both having been administered to patients for two weeks.

Some 16,000 coronavirus patients in Hong Kong have been prescribed two new oral anti-Covid drugs with favourable outcomes and few side effects being reported, according to the Hospital Authority.

The authority bought the antiviral drugs molnupiravir, made by US firm MSD, and Pfizer’s Paxlovid, with both having been administered to patients for two weeks.

Molnupiravir was given to 12,000 patients while 4,000 took Paxlovid, according to the authority. Molnupiravir was also prescribed at designated public clinics and care homes for the elderly.

Under the current guidance, the antivirals are only suitable for those aged 60 years and above.

The government has not disclosed how much of either drug it has bought, citing confidentiality agreements with the manufacturers.

Grace Lui Chung-yan, consultant in medicine at Prince of Wales Hospital in Sha Tin, on Saturday said the clinical effects of both drugs were generally good on patients, including those who were infected with Covid-19 more than once.

She said that while the side-effects were relatively mild, more time was needed before a conclusion could be drawn.

Lui also reminded patients to take the full five-day course of medicine.

Under the authority’s current guidance, both drugs are reserved for high-risk Covid-19 patients whose symptoms began within the previous five days and who are aged 60 or above.

Asked whether those aged under 60 should be given the oral antivirals, Lui said usage should be based on scientific data, noting an extremely low chance of younger patients to develop severe symptoms.

“We will not suggest all the coronavirus patients take these drugs,” she said.

She said the authority was considering introducing an antibody drug made by AstraZeneca for those who had serious immune deficiency.

“Even if they get vaccinated, the probability of their bodies producing sufficient antibodies is relatively low and the drug could provide double protection,” Lui said, emphasising that the vaccines could not be replaced.

According to health authorities, common side effects of molnupiravir are diarrhoea, headache, rashes or nausea. Those taking Paxlovid may experience side effects such as diarrhoea, slight elevation in blood pressure or muscle pain.

Molnupiravir is not suitable for pregnant women or children.

Molnupiravir by MSD, known as Merck in the United States and Canada, is not suitable for women who are pregnant or breastfeeding as it could affect fetal development. It is also not suitable for those aged under 18 as it will affect bone and cartilage growth.

Pfizer’s pill, however, can be prescribed to pregnant or breastfeeding women, and adolescents as young as 12. But the drug is not suitable for people with very weak kidney or liver functions.

Those on antibiotics or heart disease medication such as blood thinners or cholesterol drugs and are not able to stop taking them for five days are also deemed not suitable.


Related Articles

Hong Kong News
WARNING GRAPHIC CONTENT - US Memphis Police murdering innocent Tyre Nichols
Almost 30% of professionals say they've tried ChatGPT at work
Interpol seeks woman who ran elaborate exam cheating scam in Singapore
Chinese search giant Baidu to launch ChatGPT like AI chatbot.
What is ChatGPT?
Bill Gates is ‘very optimistic’ about the future: ‘Better to be born 20 years from now...than any time in the past’
China is opening up for foreign investors.
Tesla reported record profits and record revenues for 2022
Prince Andrew and Virginia Giuffre Photo Is Fake: Ghislaine Maxwell
Moonwalker Buzz Aldrin Gets Married On His 93rd Birthday
Federal Reserve Probes Goldman’s Consumer Business
China's first population drop in six decades
Microsoft is finalising plans to become the latest technology giant to reduce its workforce during a global economic slowdown
China's foreign ministry branch in Hong Kong urges British gov't to stop the biased and double standards Hong Kong report
China relaxes 'red lines' on property sector borrowing in policy pivot
Tesla slashes prices globally by as much as 20 percent
Japan prosecutors indict man for ex-PM Shinzo Abe murder
Vietnam removes two deputy PMs amid anti-corruption campaign
1.4 Million Copies Of Prince Harry's Memoir 'Spare' Sold On 1st Day In UK
After Failing To Pay Office Rent, Twitter May Sell User Names
FIFA president questioned by prosecutors
Britain's Sunak breaks silence and admits using private healthcare
Hype and backlash as Harry's memoir goes on sale. Unnamed royal source says prince 'kidnapped by cult of psychotherapy and Meghan'
China’s recovery could add 1% to Australia’s GDP: JPMorgan 
Saudi Arabia set to overtake India as fastest-growing major economy this year 
China vows to strengthen financial support for enterprises: official
International medical experts speak out against COVID-19 restrictions on China
2 Billion People To Travel In China's "Great Migration" Over Next 40 Days
Google and Facebook’s dominance in digital ads challenged by rapid ascent of Amazon and TikTok
Flight constraints expected to weigh on China travel rebound
Billionaire Jack Ma relinquishes control of Ant Group
FTX fraud investigators are digging deeper into Sam Bankman-Fried's inner circle – and reportedly have ex-engineer Nishad Singh in their sights
Teslas now over 40% cheaper in China than US
TikTok CEO Plans to Meet European Union Regulators
UK chaos: Hong Kong emigrants duped by false prospectus
China seeks course correction in US ties but will fight ‘all forms of hegemony’, top diplomat Wang Yi says
China will boost spending in 2023
African traders welcome end of China’s Covid travel curbs
France has banned the online sale of paracetamol until February, citing ongoing supply issues
Japan reportedly to give families 1 million yen per child to move out of Tokyo
Will Canada ever become a real democracy?
Hong Kong property brokerages slash payrolls in choppy market
U.S. Moves to Seize Robinhood Shares, Silvergate Accounts Tied to FTX
Effect of EU sanctions on Moscow is ‘less than zero’ – Belgian MEP
Coinbase to Pay $100 Million in Settlement With New York Regulator
Preparations begin for Spring Festival travel rush
Domestic COVID-19 drug effective in trial
HK to see a full recovery, John Lee says in New Year message
Bargain hunters flock to last day of Hong Kong brands and products expo
Hong Kong aims for January 8 reopening of border with mainland China